Literature DB >> 27582609

Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review.

Matthew Ryan Macey1, Mathew C Raynor1.   

Abstract

Benign prostatic hyperplasia (BPH) with lower urinary tract symptoms (LUTS) is one of the most common ailments affecting aging men. Symptoms typically associated with BPH include weak stream, hesitancy, urgency, frequency, and nocturia. More serious complications of BPH include urinary retention, gross hematuria, bladder calculi, recurrent urinary tract infection, obstructive uropathy, and renal failure. Evaluation of BPH includes a detailed history, objective assessment of urinary symptoms with validated questionnaires, and measurement of bladder function parameters, including uroflowmetry and postvoid residual. In general, treatment of LUTS associated with BPH is based on the effect of the symptoms on quality of life (QOL) and include medical therapy aimed at reducing outlet obstruction or decreasing the size of the prostate. If medical therapy fails or is contraindicated, various surgical options exist. As the elderly population continues to grow, the management of BPH will become more common and important in maintaining patient's QOL.

Entities:  

Keywords:  benign prostatic hyperplasia; interventional radiology; lower urinary tract symptoms; transurethral resection of the prostate

Year:  2016        PMID: 27582609      PMCID: PMC5005076          DOI: 10.1055/s-0036-1586142

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  51 in total

Review 1.  A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.

Authors:  Mauro Gacci; Giovanni Corona; Matteo Salvi; Linda Vignozzi; Kevin T McVary; Steven A Kaplan; Claus G Roehrborn; Sergio Serni; Vincenzo Mirone; Marco Carini; Mario Maggi
Journal:  Eur Urol       Date:  2012-02-25       Impact factor: 20.096

Review 2.  BPH: epidemiology and comorbidities.

Authors:  Kevin T McVary
Journal:  Am J Manag Care       Date:  2006-04       Impact factor: 2.229

3.  Characterization and localization of prostatic alpha 1 adrenoceptors using radioligand receptor binding on slide-mounted tissue section.

Authors:  S Kobayashi; R Tang; E Shapiro; H Lepor
Journal:  J Urol       Date:  1993-12       Impact factor: 7.450

4.  Holmium laser resection v transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up.

Authors:  P J Gilling; K M Kennett; M R Fraundorfer
Journal:  J Endourol       Date:  2000-11       Impact factor: 2.942

5.  Effects of finasteride on the vascular surface density, number of microvessels and vascular endothelial growth factor expression of the rat prostate.

Authors:  A Erdem Canda; M Ugur Mungan; Osman Yilmaz; Kutsal Yorukoglu; Emre Tuzel; Ziya Kirkali
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

6.  Evaluation and treatment of lower urinary tract symptoms in older men.

Authors:  P Abrams; C Chapple; S Khoury; C Roehrborn; J de la Rosette
Journal:  J Urol       Date:  2009-02-23       Impact factor: 7.450

7.  Urologic diseases in America project: benign prostatic hyperplasia.

Authors:  John T Wei; Elizabeth Calhoun; Steven J Jacobsen
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

Review 8.  Established medical therapy for benign prostatic hyperplasia.

Authors:  Gregory B Auffenberg; Brian T Helfand; Kevin T McVary
Journal:  Urol Clin North Am       Date:  2009-11       Impact factor: 2.241

Review 9.  Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.

Authors:  Gerald Andriole; Nicholas Bruchovsky; Leland W K Chung; Alvin M Matsumoto; Roger Rittmaster; Claus Roehrborn; David Russell; Donald Tindall
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

10.  Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique.

Authors:  Werner W Hochreiter; George N Thalmann; Fiona C Burkhard; Urs E Studer
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

View more
  4 in total

1.  Clinical optimal dose of solifenacin succinate for nursing patients after transurethral resection of the prostate during the perioperative period.

Authors:  Baodi Zhang; Jia Wei; Xuan Wu; Lei Wang; Hongdan Huo; Junrong Wang
Journal:  Exp Ther Med       Date:  2017-11-27       Impact factor: 2.447

2.  Robotic Freyer's prostatectomy: Operative technique and single-center experience.

Authors:  Santosh S Waigankar; Thyavihally B Yuvaraja; Preetham Dev; Varun Agarwal; Abhinav P Pednekar; Bijal Kulkarni
Journal:  Indian J Urol       Date:  2021-07-01

3.  NLRP3/IL-1β mediates denervation during bladder outlet obstruction in rats.

Authors:  Robin Lütolf; Francis M Hughes; Brian M Inouye; Huixia Jin; Jennifer C McMains; Elena S Pak; Johanna L Hannan; J Todd Purves
Journal:  Neurourol Urodyn       Date:  2017-10-06       Impact factor: 2.696

4.  Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial.

Authors:  Saturnino Napal Lecumberri; Iñigo Insausti Gorbea; Ana Sáez de Ocáriz García; Saioa Solchaga Álvarez; José Luis Cebrián Lostal; Raquel Monreal Beortegui; Pedro José Giral Villalta; Fermín Urtasun Grijalba
Journal:  Res Rep Urol       Date:  2018-02-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.